4.7 Article

LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation

Journal

CELL DEATH & DISEASE
Volume 13, Issue 11, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41419-022-05359-7

Keywords

-

Categories

Funding

  1. Key Program of Zhejiang Provincial Natural Science Foundation of China [LZ20H160001]
  2. Key R&D Program of Zhejiang Province of China [2021C03126]
  3. Medical Health Science and Technology Key Project of Zhejiang Provincial Health Commission [WKJ-ZJ-2007]
  4. National Natural Science Foundation of China [81872112, 82072857]
  5. CAMS Innovation Fund for Medical Sciences (CIFMS) [2019-I2M-5-044]
  6. Leading Innovative and Entrepreneur Team Introduction Program of Zhejiang [2019R01001]

Ask authors/readers for more resources

In this study, the researchers identified and explored the function and mechanism of long non-coding RNA surfactant associated 1 (SFTA1P) in cervical cancer. They found that SFTA1P is upregulated in cervical tumor tissues and its high expression is associated with poor prognosis. Knockdown of SFTA1P inhibited the proliferation, migration, and invasion of cervical cancer cells in vitro, as well as tumorigenesis and metastasis in vivo. Mechanistically, SFTA1P was shown to interact with polypyrimidine tract binding protein 1 (PTBP1) to regulate the stability of tropomyosin 4 (TPM4) mRNA, thereby resulting in malignant cell phenotypes. These findings provide a potential therapeutic strategy to target the SFTA1P-PTBP1-TPM4 axis in cervical cancer.
Long non-coding RNAs (lncRNAs) play key roles in cancer development and progression. However, the biological function and clinical significance of most lncRNAs in cervical cancer remain elusive. In this study, we explore the function and mechanism of lncRNA surfactant associated 1 (SFTA1P) in cervical cancer. We firstly identified SFTA1P by analyzing the RNA sequencing data of cervical cancer from our previous study and from The Cancer Genome Atlas (TCGA). We then verified SFTA1P expression by qRT-PCR. The cell proliferation and migration capacity of SFTA1P was assessed by using CCK-8, colony formation, transwell and wound healing assays. RNA pull-down, RNA immunoprecipitation (RIP), RNA stability and western blot assays were used to reveal potential mechanisms. Athymic nude mice were used to evaluate tumorigenicity and metastasis in vivo. SFTA1P is upregulated in cervical tumor tissues and its high expression is associated with poor prognosis. Biologically, knockdown of SFTA1P inhibited the proliferation, migration, and invasion of cervical cancer cells in vitro, as well as tumorigenesis and metastasis in vivo. Mechanistically, SFTA1P was shown to interact with polypyrimidine tract binding protein 1 (PTBP1) to regulate the stability of tropomyosin 4 (TPM4) mRNA, thereby resulting in malignant cell phenotypes. TPM4 knockdown could attenuate the suppression of cell progression induced by either SFTA1P or PTBP1 knockdown. Our findings demonstrate that SFTA1P can promote tumor progression by mediating the degradation of TPM4 mRNA through its interaction with PTBP1 protein. This provides a potential therapeutic strategy to target the SFTA1P-PTBP1-TPM4 axis in cervical cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available